Search research articles
Contact Us
Filters
Showing results (11-20 of 82) with videos related to
Page
of 9
Sort By:
Veterinary Journal (London, England : 1997)
|
June 11, 2013
Prednisolone inclusion in a first-line multidrug cytostatic protocol for the treatment of canine lymphoma does not affect therapy results
M Zandvliet, G R Rutteman, E Teske
Tijdschrift Voor Diergeneeskunde
|
March 1, 2006
[Hemangiosarcoma in a dog]
E Teske, G R Rutteman, J Kirpensteijn
Tijdschrift Voor Diergeneeskunde
|
March 21, 2007
[A mastocytoma in a dog]
E Teske, J Kirpensteijn, G R Rutteman
Tijdschrift Voor Diergeneeskunde
|
March 15, 1988
[Chemotherapy of tumors in dogs]
B A Austie, G R Rutteman, W Misdorp
Veterinary and Comparative Oncology
|
September 17, 2009
Immunohistochemical evaluation of p53 expression with different antibodies in malignant canine tumours with or without p53 gene mutation
A Zacchetti, E van Garderen, G R Rutteman
The Veterinary Record
|
August 13, 1988
Proligestone and diabetes mellitus
G R Rutteman, A Rijnberk, B E Belshaw
The Veterinary Quarterly
|
May 13, 1999
Evaluation of the results of a L-asparaginase-based continuous chemotherapy protocol versus a short doxorubicin-based induction chemotherapy protocol in dogs with malignant lymphoma
C J Piek, G R Rutteman, E Teske
Anticancer Research
|
July 1, 1989
Cytogenetic analysis of cell lines derived from metastases of a mammary carcinoma in a dog
C H Mellink, A A Bosma, G R Rutteman
Veterinary and Comparative Oncology
|
November 15, 2011
A randomized controlled study into the efficacy and toxicity of pegylated liposome encapsulated doxorubicin as an adjuvant therapy in dogs with splenic haemangiosarcoma
E Teske, G R Rutteman, J Kirpenstein, et al.
Veterinary and Comparative Oncology
|
April 12, 2012
Intraperitoneal antineoplastic drug delivery: experience with a cyclophosphamide, vincristine and prednisolone protocol in cats with malignant lymphoma
E Teske, A J van Lankveld, G R Rutteman
Page
of 9
Search research articles
Search
Showing results (11-20 of 82) with videos related to
Sort By:
Page
of 9
Veterinary Journal (London, England : 1997)
|
June 11, 2013
Prednisolone inclusion in a first-line multidrug cytostatic protocol for the treatment of canine lymphoma does not affect therapy results
M Zandvliet, G R Rutteman, E Teske
Tijdschrift Voor Diergeneeskunde
|
March 1, 2006
[Hemangiosarcoma in a dog]
E Teske, G R Rutteman, J Kirpensteijn
Tijdschrift Voor Diergeneeskunde
|
March 21, 2007
[A mastocytoma in a dog]
E Teske, J Kirpensteijn, G R Rutteman
Tijdschrift Voor Diergeneeskunde
|
March 15, 1988
[Chemotherapy of tumors in dogs]
B A Austie, G R Rutteman, W Misdorp
Veterinary and Comparative Oncology
|
September 17, 2009
Immunohistochemical evaluation of p53 expression with different antibodies in malignant canine tumours with or without p53 gene mutation
A Zacchetti, E van Garderen, G R Rutteman
The Veterinary Record
|
August 13, 1988
Proligestone and diabetes mellitus
G R Rutteman, A Rijnberk, B E Belshaw
The Veterinary Quarterly
|
May 13, 1999
Evaluation of the results of a L-asparaginase-based continuous chemotherapy protocol versus a short doxorubicin-based induction chemotherapy protocol in dogs with malignant lymphoma
C J Piek, G R Rutteman, E Teske
Anticancer Research
|
July 1, 1989
Cytogenetic analysis of cell lines derived from metastases of a mammary carcinoma in a dog
C H Mellink, A A Bosma, G R Rutteman
Veterinary and Comparative Oncology
|
November 15, 2011
A randomized controlled study into the efficacy and toxicity of pegylated liposome encapsulated doxorubicin as an adjuvant therapy in dogs with splenic haemangiosarcoma
E Teske, G R Rutteman, J Kirpenstein, et al.
Veterinary and Comparative Oncology
|
April 12, 2012
Intraperitoneal antineoplastic drug delivery: experience with a cyclophosphamide, vincristine and prednisolone protocol in cats with malignant lymphoma
E Teske, A J van Lankveld, G R Rutteman
Page
of 9